Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Argentina

Takeda To Expand To Emerging Markets

November 2009 | Industry Trend Analysis

Japan's largest drugmaker, Takeda, has announced that it plans to enter the South American drug market via the acquisition of a generic drugmaker in the region, though the company is yet to elaborate on any potential targets. BMI believes that a major push by Takeda into such regions is inevitable - of the firms included in our inaugural Pharmaceutical Emerging Markets Sales Index (PEMSI), Takeda has the smallest exposure to emerging markets.[1] The drug company recorded the majority of sales during 2008 in its domestic market (US$7.66bn), followed by North America (US$5.21bn) and Europe (US$2.29bn). Revenue in other countries was

To read the full article, please choose one of the following options:

Subcribers please log in